Financial Performance - The company expects a net loss attributable to shareholders of approximately 29 million to 21 million CNY, compared to a loss of 33.23 million CNY in the same period last year[2]. - The expected loss excluding non-recurring gains and losses is projected to be between 27 million to 19 million CNY, down from a loss of 36.13 million CNY year-over-year[2]. - Basic earnings per share are anticipated to be a loss of 0.79 to 0.57 CNY per share, compared to a loss of 0.89 CNY per share in the previous year[2]. Asset Impairment and Provisions - The company has recognized asset impairment provisions totaling approximately 68 million CNY, impacting the net profit significantly[4]. - Non-recurring gains and losses are primarily related to provisions for expected liabilities from a terminated agreement and litigation outcomes, estimated to impact net profit by about 31.5 million CNY[5]. Market Conditions - The agricultural chemicals segment faced low market demand, leading to a decline in sales prices and gross profit margins[4]. - The photovoltaic segment experienced intensified market competition, resulting in significant losses despite a substantial increase in product shipment volumes[4]. Reporting and Audit - The financial data presented is preliminary and subject to audit, with final figures to be disclosed in the 2024 annual report[6].
蓝丰生化(002513) - 2024 Q4 - 年度业绩预告